Omega Fund Management »

Syros Pharmaceuticals shares owned by Omega Fund Management

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 251k 7.79
2023-09-30 $993k 251k 3.95
2023-06-30 $792k 251k 3.15
2023-03-31 $671k 251k 2.67
2022-12-31 $902k 251k 3.59
2022-09-30 $1.6M 251k 6.44

More positions owned by Omega Fund Management

Lexeo Therapeutics Common Stock (LXEO)
Replimune Group Common Stock (REPL)
Nuvation Bio Common Stock Class A (NUVB)
enGene Holdings Common Stock (ENGN)
Morphic Holding Common Stock (MORF)
Spruce Biosciences Common Stock (SPRB)
Kronos Bio Common Stock (KRON)
Ikena Oncology Common Stock (IKNA)
Sana Biotechnology Common Stock (SANA)
Theseus Pharmaceuticals Common Stock
Immunic Common Stock (IMUX)
Syros Pharmaceuticals Common Stock (SYRS)
enGene Holdings Warrant (ENGNW)
Senti Biosciences Common Stock (SNTI)

View all positions for Omega Fund Management

Top funds holding Syros Pharmaceuticals

Artal Group
Samsara BioCapital
Avidity Partners Management
Blue Owl Capital Holdings
Point72 Asset Management
Flagship Ventures Management
Vanguard Group
Opaleye Management
Omega Fund Management
Goldman Sachs Group
DAFNA Capital Management
Assenagon Asset Management
Tang Capital Management
Lgt Capital Partners
Two Sigma Investments

View all funds holding Syros Pharmaceuticals